The Effect of DPP4 Inhibitor on Glycemic Variability in Patients with Type 2 Diabetes treated with twice-daily Premixed Human Insulin

Objective. To evaluate the effect of adding DPP4 inhibitor (DPP4-I) on glycemic variability (GV) in patients with type 2 diabetes mellitus (T2DM) treated with premixed human insulin (MHI). Methodology. We conducted a prospective study in patients with T2DM on twice-daily MHI with or without metfo...

Full description

Bibliographic Details

Published in:	Journal of the ASEAN Federation of Endocrine Societies
Main Authors:	Florence Hui Sieng Tan, Chin Voon Tong, Xun Ting Tiong, Bik Kui Lau, Yueh Chien Kuan, Huai Heng Loh, Saravanan Vengadesa Pillai
Format:	Article
Language:	English
Published:	ASEAN Federation of Endocrine Societies 2022-07-01
Subjects:	glycemic variability dipeptidyl peptidase 4 inhibitors premixed human insulin continuous glucose monitoring type 2 diabetes mellitus
Online Access:	https://asean-endocrinejournal.org/index.php/JAFES/article/view/1053